Latest News
Altimmune, Inc.
- Altimmune, Inc. Estimates – TRADEGATE:3G0
- Altimmune to present pemvidutide liver disease data at AASLD By Investing.com
- Altimmune Inc. Advanced Charts | ALT
- MetaVia Appoints Former Altimmune Executive Sarah Browne, M.D., as Chief Medical Officer
- Altimmune (ALT) Ticks Up 0.38% to $2.61 as Shares Consolidate Between Key Levels - Aggressive Growth Picks
- Altimmune (NasdaqGM:ALT) Stock Forecast & Analyst Predictions
- Altimmune Details Pemvidutide’s Path Toward a Liver-Disease Franchise
- Altimmune Appoints Richard Menziuso as Principal Accounting Officer
- Altimmune at Stifel 2026 Virtual Cardiometabolic Forum: liver push By Investing.com
- Altimmune appoints Richard Menziuso as VP, Global Controller and Principal Accounting Officer
- Form 8K Altimmune Inc For: 29 September By Investing.com
- Altimmune appoints Richard Menziuso as vice president and principal accounting officer
Headlines from the last 30 days, linking to the original publishers. See all market news →